January 27th 2023
By Colleen Moretti
The Food and Drug Administration approved Orserdu for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.
January 27th 2023
By Brielle Benyon
The Food and Drug Administration approved Jaypirca for patients with relapsed/refractory mantle cell lymphoma who have been previously treated with multiple lines of therapy.
January 27th 2023
By Bonnie Annis
I always viewed my doctors as being unapproachable on a personal level. I thought they were there to examine and diagnose me, imparting wisdom I could never hope to attain, but one day I realized I was very wrong.
January 27th 2023
By Brielle Benyon
From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.
January 27th 2023
By Brielle Benyon
VIC-1911 will be studied alone or with Lumakras in patients with KRAS G12C-mutant non-small cell lung cancer.
January 27, 2023 6:00 PM
By Bonnie Annis
January 26, 2023 6:00 PM
By Natasha Carlson
January 25, 2023 6:00 PM
By William Ramshaw
January 24, 2023 6:00 PM
By Mark Hicks
January 4, 2023 4:00 PM
December 30, 2022 8:00 PM
December 30, 2022 2:00 PM
December 29, 2022 8:00 PM
January 26, 2023 2:00 PM
By Stephanie Landon
January 25, 2023 4:00 PM
By Shoba Rao
January 23, 2023 8:00 PM
By John Smelcer, PhD, CAGS
January 4, 2023 8:00 PM
By Ngozi Ejedimu